The aim of the new variations framework is to streamline post-approval change handling, particularly the assessment and processing of variations.
Key takeaways
Scope & purpose
When it applies
What’s coming next
Who is affected?
Marketing Authorization Holders (MAHs) for medicinal products authorised in the EU via the Centralised Procedure or National Procedures such as the Decentralised and Mutual-Recognition Procedure should be aware of the updated legislation and guidance.
How QbD Group can support
Conduct a focused review of SOPs
pending change controls and planned submissions to ensure alignment with the requirements detailed in the new framework.
Author Variation submissions
We can offer comprehensive post-approval support, starting from analysis of the initial change control, to preparation and review of documentation, eCTD publishing, submission and approval.
Provide training
training on the application of the new framework, covering key changes to grouping, worksharing, classification of changes, updated document requirements and consequential impacts to regulatory strategy. Other complimentary changes can be covered, such as implementation of the Product Lifecycle Management (PLM) Portal.
If you are looking for comprehensive Regulatory Intelligence support that monitors changes to key legislation and guidance, please don’t hesitate to get in touch with one of our experts today!